Julia Greenstein discusses JDRF research into how beta cell stress and the immune system are contributing to the pathways of initiating and continuing the destruction of the beta cells in type 1 diabetes.

In this Exclusive Interview, Dr. Julia Greenstein talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the work at the JDRF to prevent diabetes and the encouraging results of the use of a cancer drug as a possible diabetes treatment.